303 related articles for article (PubMed ID: 18577289)
21. Event-based prospective memory in newly diagnosed, drug-naive Parkinson's disease patients.
Pagni C; Frosini D; Ceravolo R; Giunti G; Unti E; Poletti M; McClintock SM; Murri L; Bonuccelli U; Tognoni G
J Int Neuropsychol Soc; 2011 Nov; 17(6):1158-62. PubMed ID: 22014082
[TBL] [Abstract][Full Text] [Related]
22. Long-term clinical evaluation in patients with Parkinson's disease and early autonomic involvement.
Lucetti C; Gambaccini G; Del Dotto P; Ceravolo R; Logi C; Rossi G; Murri L; Bonuccelli U
Parkinsonism Relat Disord; 2006 Jun; 12(5):279-83. PubMed ID: 16549382
[TBL] [Abstract][Full Text] [Related]
23. Memory for time intervals is impaired in left hemi-Parkinson patients.
Koch G; Brusa L; Oliveri M; Stanzione P; Caltagirone C
Neuropsychologia; 2005; 43(8):1163-7. PubMed ID: 15817174
[TBL] [Abstract][Full Text] [Related]
24. Surface electromyography shows increased mirroring in Parkinson's disease patients without overt mirror movements.
Cincotta M; Giovannelli F; Borgheresi A; Balestrieri F; Vanni P; Ragazzoni A; Zaccara G; Ziemann U
Mov Disord; 2006 Sep; 21(9):1461-5. PubMed ID: 16705686
[TBL] [Abstract][Full Text] [Related]
25. The effect of levodopa on respiration and word intelligibility in people with advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Van Maele G; Van Borsel J; Boon P
Clin Neurol Neurosurg; 2007 Jul; 109(6):495-500. PubMed ID: 17509751
[TBL] [Abstract][Full Text] [Related]
26. Dopaminergic basis for deficits in working memory but not attentional set-shifting in Parkinson's disease.
Lewis SJ; Slabosz A; Robbins TW; Barker RA; Owen AM
Neuropsychologia; 2005; 43(6):823-32. PubMed ID: 15716155
[TBL] [Abstract][Full Text] [Related]
27. Dopaminergic modulation of prospective memory in Parkinson's disease.
Costa A; Peppe A; Brusa L; Caltagirone C; Gatto I; Carlesimo GA
Behav Neurol; 2008; 19(1-2):45-8. PubMed ID: 18413916
[TBL] [Abstract][Full Text] [Related]
28. The dopamine agonist piribedil with L-DOPA improves attentional dysfunction: relevance for Parkinson's disease.
Turle-Lorenzo N; Maurin B; Puma C; Chezaubernard C; Morain P; Baunez C; Nieoullon A; Amalric M
J Pharmacol Exp Ther; 2006 Nov; 319(2):914-23. PubMed ID: 16920993
[TBL] [Abstract][Full Text] [Related]
29. Reevaluation of levodopa therapy for the treatment of advanced Parkinson's disease.
Yokochi M
Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S25-30. PubMed ID: 19131038
[TBL] [Abstract][Full Text] [Related]
30. Levodopa-induced alterations in speech rate in advanced Parkinson's disease.
De Letter M; Santens P; De Bodt M; Boon P; Van Borsel J
Acta Neurol Belg; 2006 Mar; 106(1):19-22. PubMed ID: 16776432
[TBL] [Abstract][Full Text] [Related]
31. Pain intensity on and off levodopa in patients with Parkinson's disease.
Nebe A; Ebersbach G
Mov Disord; 2009 Jun; 24(8):1233-7. PubMed ID: 19412949
[TBL] [Abstract][Full Text] [Related]
32. A dopamine agonist, pramipexole, and cognitive functions in Parkinson's disease.
Relja M; Klepac N
J Neurol Sci; 2006 Oct; 248(1-2):251-4. PubMed ID: 16797593
[TBL] [Abstract][Full Text] [Related]
33. Motor program memory storage in Parkinson's disease patients tested with a delayed response task.
Labutta RJ; Miles RB; Sanes JN; Hallett M
Mov Disord; 1994 Mar; 9(2):218-22. PubMed ID: 8196687
[TBL] [Abstract][Full Text] [Related]
34. Chronic levodopa intake increases levodopa plasma bioavailability in patients with Parkinson's disease.
Muhlack S; Woitalla D; Welnic J; Twiehaus S; Przuntek H; Müller T
Neurosci Lett; 2004 Jun; 363(3):284-7. PubMed ID: 15182961
[TBL] [Abstract][Full Text] [Related]
35. Hand coordination as a quantitative measure of motor abnormality and therapeutic response in Parkinson's disease.
Benice TS; Lou JS; Eaton R; Nutt J
Clin Neurophysiol; 2007 Aug; 118(8):1776-84. PubMed ID: 17576094
[TBL] [Abstract][Full Text] [Related]
36. Levodopa and executive performance in Parkinson's disease: a randomized study.
Pascual-Sedano B; Kulisevsky J; Barbanoj M; García-Sánchez C; Campolongo A; Gironell A; Pagonabarraga J; Gich I
J Int Neuropsychol Soc; 2008 Sep; 14(5):832-41. PubMed ID: 18764978
[TBL] [Abstract][Full Text] [Related]
37. Quantitative study of salivary secretion in Parkinson's disease.
Tumilasci OR; Cersósimo MG; Belforte JE; Micheli FE; Benarroch EE; Pazo JH
Mov Disord; 2006 May; 21(5):660-7. PubMed ID: 16419045
[TBL] [Abstract][Full Text] [Related]
38. Impaired reproduction of second but not millisecond time intervals in Parkinson's disease.
Koch G; Costa A; Brusa L; Peppe A; Gatto I; Torriero S; Gerfo EL; Salerno S; Oliveri M; Carlesimo GA; Caltagirone C
Neuropsychologia; 2008 Apr; 46(5):1305-13. PubMed ID: 18215403
[TBL] [Abstract][Full Text] [Related]
39. [Early treatment of Parkinson's disease with levodopa].
Odekerken VJ; Post B; Verschuur CV; de Bie RM
Ned Tijdschr Geneeskd; 2009; 153():A286. PubMed ID: 19785822
[TBL] [Abstract][Full Text] [Related]
40. Pulmonary functions in Parkinson's disease.
Sathyaprabha TN; Kapavarapu PK; Pall PK; Thennarasu K; Raju TR
Indian J Chest Dis Allied Sci; 2005; 47(4):251-7. PubMed ID: 16255396
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
